King Andrew James (CIK 1823187) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-13). Recent activity: Buy JBIO (41,250 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-13 | Jade Biosciences, Inc. (JBIO) | Chief Scientific Officer & Head of Research and Development | Buy | 41,250 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-02-13